BioCentury
ARTICLE | Clinical News

SEPA delivery of prostaglandin E1: MCHM started Phase I/II trials

May 20, 1996 7:00 AM UTC

MacroChem Corp. (MCHM), Lexington, Mass. Product: SEPA delivery of prostaglandin E1 Indication: Erectile dysfunction. Status: MCHM started Phase I/II trials of its topical SEPA gel formulation of pros...